HEMISPHERX BIOPHARMA, INC

Inactive Instrument

Transcripts Hemispherx BioPharma, Inc Nyse

Equities

US42366C1036

End-of-day quote Nyse Other stock markets
- ^USD	-

29/04	AIM ImmunoTech Says Safety Evaluation of First Dose Level of Pancreatic Cancer Study Completed	MT
10/04	AIM Immunotech Announces Positive Top-Line, Protocol-Planned Interim Report Data from the Study of Ampligen Combined with Pembrolizumab for the Treatment of Recurrent Ovarian Cancer	CI

Transcripts

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : AIM ImmunoTech Inc., Q4 2023 Earnings Call, Apr 02, 2024	02/04
Transcript : AIM ImmunoTech Inc. - Special Call	20/03
Transcript : AIM ImmunoTech Inc. - Pre Recorded Special Call	10/01
Transcript : AIM ImmunoTech Inc., Q3 2023 Earnings Call, Nov 15, 2023	15/11
Transcript : AIM ImmunoTech Inc., Q2 2023 Earnings Call, Aug 15, 2023	15/23/15
Transcript : Hemispherx Biopharma, Inc., Q2 2017 Earnings Call, Aug 15, 2017	15/17/15
Transcript : Hemispherx Biopharma, Inc., 2016 Earnings Call, Apr 07, 2017	07/17/07
Transcript : Hemispherx Biopharma, Inc., Q3 2016 Earnings Call, Nov 15, 2016	15/16/15
Transcript : Hemispherx Biopharma, Inc., Q2 2016 Earnings Call, Aug 19, 2016	19/16/19
Transcript : Hemispherx Biopharma, Inc., Q1 2016 Earnings Call, May 17, 2016	17/16/17
Transcript : Hemispherx Biopharma, Inc., 2015 Earnings Call, Mar 30, 2016	30/16/30
Transcript : Hemispherx Biopharma, Inc., 2011 Earnings Call, Mar 22, 2012	22/12/22

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW